High-throughput screening for class I peptide MHC binding via yeast surface display
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2514741122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Patrick V Holec und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139. Hauptthemen laut MEDLINE: High-Throughput Screening Assays, Histocompatibility Antigens Class I, Peptides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH (NIH), NSF | NSF Graduate Research Fellowship Program (GRFP), NIAID NIH HHS.
Abstract (Originalsprache)
T cells rely on short peptides presented by highly polymorphic major histocompatibility complexes (MHCs) to selectively initiate adaptive immune responses. Despite its importance, few techniques can systematically evaluate stable peptide presentation across diverse MHC alleles. Here, we describe a yeast display pipeline that can be deployed to rapidly screen peptides to identify class I pMHC binders across many alleles. Through this, we isolate unique biological phenomena such as alteration of the peptide presentation of HLA-B57 via interaction with the antiviral small molecule abacavir. We apply this approach to multiple pathogen proteomes ( Mycobacterium tuberculosis Type VII secretion substrates, SARS-CoV-2, Dengue, and Zika) to create a comprehensive list of potential T cell antigens. Altogether, this platform acts as a flexible tool to generate large unbiased datasets for class I peptide binding at a speed and scale competitive with the biological systems they represent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139.
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
- Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge, MA 02139.
ORCID-Profile: Patrick V Holec, Kathryn C Breuckman, Forest M White, Bryan D Bryson, Michael E Birnbaum
Förderung
- HHS | NIH (NIH)
- NSF | NSF Graduate Research Fellowship Program (GRFP)
- NIAID NIH HHS
- NIEHS NIH HHS
- Schmidt Futures (Schmidt Futures Projects, LLC)
- David and Lucile Packard Foundation (PF)
Zitieren
APA
Holec, P. V., Breuckman, K. C., Leddy, O., White, F. M., Bryson, B. D., & Birnbaum, M. E. (2025). High-throughput screening for class I peptide MHC binding via yeast surface display. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2514741122
Vancouver
Holec PV, Breuckman KC, Leddy O, White FM, Bryson BD, Birnbaum ME. High-throughput screening for class I peptide MHC binding via yeast surface display. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2514741122
BibTeX
@article{Holec2025,
author = {Holec, Patrick V and Breuckman, Kathryn C and Leddy, Owen and White, Forest M and Bryson, Bryan D and Birnbaum, Michael E},
title = {High-throughput screening for class I peptide MHC binding via yeast surface display},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2514741122}
}
EUVIMED